File size: 3,550 Bytes
e2b0927
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
### Definitions for Impact, Consultation, and Awareness in Regulatory Intelligence

#### **1. Impact (High-Risk Insights)**  
Impactful insights are those with **immediate or significant implications** for GSK's regulatory compliance, market access, or product lifecycle. These insights require urgent action or changes to processes, policies, or strategies due to their potential to:  
- **Directly affect patient safety** or public health.  
- Lead to **non-compliance** with critical regulatory standards.  
- Result in **financial, reputational, or legal penalties**.  
- Trigger **supply chain disruptions** or product recalls.  

**Characteristics of Impactful Insights:**  
- High **urgency** and **priority** for decision-making.  
- Minimal need for validation or consultation; the evidence and risk are clear.  
- **Examples:** Changes in regulatory standards affecting product approval, urgent safety communications from regulatory authorities, or enforcement actions.

---

#### **2. Consultation (Medium-Level Insights)**  
Insights requiring consultation are those that **pose a potential risk or opportunity** but lack sufficient clarity, data, or context to enable direct action. These insights demand collaboration with domain experts or cross-functional teams to assess their significance and develop an appropriate response.  

**Characteristics of Consultation Insights:**  
- **Moderate level of risk or opportunity**; impacts are not immediate but could escalate.  
- Require **validation**, deeper analysis, or alignment across teams.  
- **Examples:** Regulatory trends, proposed policy changes, or emerging technologies that could impact GSK's operations if adopted.  

**Key Stakeholders for Consultation:**  
- Regulatory affairs, compliance teams, legal experts, and product development teams.

---

#### **3. Awareness (Low-Level Insights)**  
Awareness insights are those **informative in nature**, providing updates or context without requiring immediate action. These insights are used to **build knowledge** across the organization, ensuring teams are informed of evolving regulations, industry trends, and potential future challenges.  

**Characteristics of Awareness Insights:**  
- Low or no direct risk; mainly informational.  
- Serve as a foundation for **long-term planning** or **strategic foresight**.  
- **Examples:** General updates from regulatory authorities, industry best practices, or news about competitors' regulatory strategies.  

**Purpose of Awareness Insights:**  
- Enable GSK to **stay ahead of the curve** and prepare for potential risks or opportunities.  
- Foster a culture of **proactive compliance** and strategic adaptability. 

---

### Comparison Framework

| **Category**      | **Risk Level** | **Action Required**                    | **Examples**                                                                 |
|--------------------|----------------|----------------------------------------|-----------------------------------------------------------------------------|
| **impact**         | High           | Immediate action; directly implement changes. | Product recalls, critical safety updates, regulatory non-compliance risks.  |
| **consultation**   | Medium         | Expert analysis and collaborative decision-making. | Proposed regulatory changes, emerging trends, or ambiguous guidance.        |
| **awareness**      | Low            | Monitor and inform; no immediate action needed. | Informational updates, general regulatory trends, or competitor insights.   |